What is HD?
HD operates within the dynamic medtech and healthcare solutions sector, aiming to enhance healthcare delivery and patient outcomes. The company's strategic location in Bangkok, Thailand, positions it within a rapidly growing regional market for health technology innovation. This latest round of financing, characterized as a major strategic investment, underscores the significant interest and confidence from the investment community in HD's business model and future growth potential.
How much funding has HD raised?
HD has raised a total of $11.6M across 2 funding rounds:
Angel/Seed
$6M
Series A
$5.6M
Angel/Seed (2023): $6M with participation from AC Ventures, iSeed, and Partech International
Series A (2024): $5.6M led by FEBE Ventures, SBI Ven Capital, and M Venture Partners
Key Investors in HD
FEBE Ventures
FEBE Ventures is a global seed-focused venture capital firm founded by ex-founders, providing financial investment and support to over 200 startups across AI, health tech, and fintech, with a focus on emerging markets.
SBI Ven Capital
SBI Ven Capital is a private equity and private credit firm focused on financial services and technology in Asia, aiming to provide accessible finance solutions, particularly to under-banked populations.
M Venture Partners
M Venture Partners Pte Ltd is a Monetary Authority of Singapore registered and licensed professional Fund Manager, managing investments across various sectors.
What's next for HD?
The substantial enterprise-level funding, including the recent strategic investment, is poised to accelerate HD's expansion and product development initiatives. This capital infusion will likely support scaling operations, enhancing technological capabilities, and broadening market reach within the healthcare solutions landscape. The company's trajectory suggests a focus on solidifying its market position and potentially exploring new avenues for innovation in medtech.
See full HD company page
